EU antitrust regulators send Johnson & Johnson (JNJ -0.1%) and Novartis (NVS -0.3%) a "statement of objections," or charge sheet, over a "co-promotion" deal they formulated that delayed the release of a generic competitor to J&J's painkiller fentanyl in Holland for 17 months in 2005-2006. The EU can levy fines of up to 10% of annual sales for anti-competitive behavior, although penalties are usually based on the revenues of the product involved. (PR)
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Benzinga.com (Mon, 1:57PM)
at Nasdaq.com (Feb 19, 2015)
at Nasdaq.com (Feb 17, 2015)
at Nasdaq.com (Feb 10, 2015)
at Investor's Business Daily (Jan 20, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs